Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537-2548.Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, ...
Macular degeneration– is the leading cause of blindness among Americans over the age of 65. Dry macular degeneration causes gradual central vision loss and results from aging and thinning of tissues in the macula or deposit of pigment. Wet macular degeneration arises from the body’s attempt to ...
Diabetic macular edema (DME) is the leading cause of vision loss in people with type 1 and type 2 diabetes. DME results when damaged blood vessels leak fluid into the macula, the central portion of the retina responsible ...
Furthermore, we discuss tailored and optimized drug delivery approaches for infectious ocular diseases, outlining current challenges and future directions for developing effective ocular drug delivery systems. Keywords: ocular disease; targeted drug delivery; keratitis; conjunctivitis; endophthalmitis; infectious...
To estimate the value of macular pigment optical density (MPOD) in adult south Indian population with wet age-related macular degeneration (AMD). A total of 33 patients with wet AMD and 29 age-matched controls >50 years of age underwent MPOD measureme
Changing practice for the non-medical ophthalmic hospital workforce in the UK—a snapshot survey Article03 September 2020 Introduction The 49 countries of sub-Saharan Africa (SSA) are home to 12% of the global population, one billion people [1]. Over 4 million of the population are blind (...
Age-related macular degeneration (AMD) is one of the most common causes of irreversible blindness affecting nearly 50 million individuals globally. The disease is characterised by progressive loss of central vision, which has significant implications for
Functional vision, as evaluated with silent passage reading speed, improves after anti鈥搗ascular endothelial growth factor (anti-VEGF) treatment in patients with wet age-related macular antidegeneration (wAMD), reflecting primarily a concomitant reduction in the number of fixations. Implementing eye ...
Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology 2012;119:2537-48Jeffrey S. Heier,David M. Brown,Victor Chong,Jean-Francois Korobelnik,Peter K. Kaiser,Quan Dong Nguyen,Bernd Kirchhof,Allen Ho,Yuichiro Ogura,George D. Yancopoulos,Neil Stahl,Robert ...
Retinal pathology in the fellow eye of patients presenting with wet age-related macular degeneration in the index eyeuveitisbiologicsinfliximabadalimumabEye is the official journal of the Royal College of Ophthalmologists. It aims to provide the practising ophthalmologist with information on the latest ...